|
Intravenous immunoglobulin for CIDP |
van Schaik I, Winer J, de Haan R, Vermeulen M |
|
Immunosuppressive agents for polymyositis and dermatomyositis |
Choy E, Lecky B, Winer J, Hoogendijk J |
|
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy |
Mehndiratta MM, Hughes RAC |
|
Immunotherapy for IgM anti-Myelin-Associated Glycoprotein-associated peripheral neuropathies |
Lunn MPT, Nobile-Orazio E |
|
Drug treatment for facioscapulohumeral muscular dystrophy |
Rose M, Tawil R |
|
Glucocorticoid corticosteroids for Duchenne muscular dystrophy |
Manzur AY, Kuntzer T, Pike M |
|
Treatment for ocular myasthenia gravis |
Benatar M, Kaminski H |
|
Spinal surgery for scoliosis in Duchenne muscular dystrophy |
Ka Leung Cheuk D, Wong V, Wraige E, Elliott T, Cole A, Baxter P, Mayowe V |
|
Immunosuppressive treatment for non-systemic vasculitic neuropathy |
Vrancken A, Notermans N, Wokke J, Hughes RAC, Said G |
|
Antioxidants for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) |
Orrell R, Lane R, Ross M |
|
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
Mehndiratta MM, Hughes RAC, Agarwal P |
|
Corticosteroids for myasthenia gravis |
Schneider-Gold C, Hohlfeld R, Toyka K, Gajdos P |
|
Plasma exchange for myasthenia gravis |
Gajdos P, Toyka K |
|
Recombinant human insulin-like growth factor-1 for amyotrophic lateral sclerosis (ALS)/motor neuron disease(MND) |
Mitchell JD, Borasio G |
|
Intravenous immunoglobulin for myasthenia gravis |
Gajdos P, Toyka K |
|
Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease |
Ashworth N, Deforge D, Satkunam L |
|
Creatine for neuromuscular disease |
Kley R, Tarnopolsky M, Vorgerd M |
|
Treatment for Eaton-Lambert myasthenic syndrome |
Maddison P, Newsom-Davis J |
|
Scapular fixation for facioscapulohumeral muscular dystrophy |
Mummery C, Copeland S, Rose M |
|
Psychostimulants for hypersomnia in myotonic dystrophy |
Annane D, Miller RG, Barnes P |
|
Strength training and aerobic exercise training for muscle disease |
van der Kooi E, Lindeman E, Riphagen I |
|
Pharmacological and nutritional treatment for McArdle's disease (Glycogen storage disease V) |
Quinlivan, R, Beynon R |
|
Drug therapy for chronic idiopathic axonal polyneuropathy |
Vrancken A, van Schaik I, Hughes R, Notermans N |
|
Ciliary neurotrophic factor for amyotrophic lateral sclerosis(ALS)/motor neuron disease(MND) |
Bongioanni P Reali C, Sogos V |
|
Intravenous immunoglobulin for multifocal motor neuropathy |
Van Schaik I, Van den Berg Rh, de Haan R, Vermeulen M |
|
Immunosuppressive agents for multifocal motor neuropathy |
Umapathi T, Hughes RAC, Nobile-Orazio E, Leger J |
|
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy |
Hughes RAC, Swan A, van Doorn P |
|
Exercise for peripheral neuropathy |
White C, Turner-Stokes L, Pritchard J |
|
Treatment for mitochondrial myopathies and encephalopathies |
Chinnery P, Turnbull DM, Thorburn D, Majamaa K |
|
Enteral feeding for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) |
Langmore SE, Kasarkis E, Manca L |
|
Rehabilitation interventions for foot drop in neuromuscular disease |
Sackley C, Hoppitt T, Disler P, Turner-Stokes L, Wade D |
|
Treatment for Fisher Syndrome, Bickerstaff's brainstem encephalitis and related disorders |
Overell J, Willison H, Odaka M, Yuki N, Hsieh ST |
|
Treatment for dysphagia in chronic muscle disease |
Hill M, Hughes T, Milford C |
|
Symptomatic drug therapy for myotonia |
Trip J, Faber CG, Drost G, van Engelen BGM |
|
Treatment for IgG and IgA paraproteinaemic demyelinating neuropathy |
Allen D, Lunn M, Niermeijer J, Nobile-Orazio E |
